Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on MCP, NPSP, SLW and SPPI Issued by the Paragon Report

Free Research Reports on MCP, NPSP, SLW and SPPI Issued by the Paragon Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1004150&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwired) -- 04/05/13 -- The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Molycorp Inc. (NYSE: MCP) shares have declined nearly 50 percent so far in 2013. The company reported a net loss of $460.9 million, or $4.31 per share, for the full year 2012. Molycorp has stated that they expect results for the first half of 2013 are "likely to be slightly weaker" than previous two quarters.

Find out more about Molycorp including full access to the free equity report at: www.ParagonReport.com/MCP

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) shares have soared over 30 percent in the past month. The company has recently revised agreements with the Takeda Pharmaceutical Company and has regained full worldwide rights to teduglutide and recombinant human parathyroid hormone 1-84.

Find out more about NPS Pharmaceuticals including full access to the free equity report at: www.ParagonReport.com/NPSP

Silver Wheaton Corp. (NYSE: SLW) (TSX: SLW) shares have fallen approximately 20 percent year-to-date. Silver miners have struggled in 2013 as prices for the commodity have failed to maintain any upwards momentum. Since October, silver prices have fallen roughly 20 percent.

Find out more about Silver Wheaton including full access to the free equity report at: www.ParagonReport.com/SLW

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) shares have fallen approximately 40 percent in the past month. The company has announced that it "anticipates a change in ordering patterns of FUSILEV" and now expects FUSILEV sales to be between $10 million to $15 million for the first quarter.

Find out more about Spectrum Pharmaceuticals including full access to the free equity report at: www.ParagonReport.com/SPPI

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today